Table 2:

Association between statin dose and 1-year mortality in older Ontario residents living in long-term care facilities who were prescribed statins, overall and by subgroup*

AnalysisNo. of matched pairs analyzedOne-year survival in residents taking intensive-dose statins, %One-year survival in residents taking moderate-dose statins, %Risk difference in 1-year survival, % (95% CI)HR (95% CI)
Primary analysis, all matched pairs457774.3773.560.81 (−0.99 to 2.61)0.97 (0.90 to 1.05)
Stratified analysis
Sex
 Female277677.7076.081.62 (−0.60 to 3.84)0.93 (0.83 to 1.03)
 Male180169.2469.68−0.44 (−3.45 to 2.57)1.02 (0.91 to 1.15)
History of atherosclerotic-related admission to hospital
 No156078.7276.672.05 (−0.88 to 4.97)0.91 (0.79 to 1.05)
 Yes301772.1271.960.16 (−2.11 to 2.43)1.00 (0.91 to 1.09)
Frailty status
 Prefrail or not frail211982.7783.48−0.71 (−2.97 to 1.55)1.05 (0.91 to 1.21)
 Frail245867.1365.012.12 (−0.53 to 4.77)0.93 (0.85 to 1.03)
  • Note: CI = confidence interval, HR = hazard ratio.

  • * Statins prescribed between Apr. 1, 2013, and Mar. 31, 2014.

  • Residents taking moderate-dose statins served as the reference category.